Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure-Reference-Cited by-同舟云学术

Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure

Published:2010-05-25 Issue:14 Volume:31 Page:1752-1763
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Núñez Julio,Sanchis Juan,Bodí Vicent,Fonarow Gregg C.,Núñez Eduardo,Bertomeu-González Vicente,Miñana Gema,Consuegra Luciano,Bosch Maria José,Carratalá Arturo,Chorro Francisco J.,Llàcer Angel

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/31/14/1752/17048796/ehq142.pdf

Reference35 articles.

1. The search for new cardiovascular biomarkers;Nature,2008

2. The Seattle Heart Failure Model: prediction of survival in heart failure;Circulation,2006

3. Prognostic value of brain natriuretic peptide in acute heart failure: mortality and hospital readmission;Rev Esp Cardiol,2008

4. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure;Am Heart J,2008

5. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure;ADHERE Scientific Advisory Committee, Investigators;J Am Coll Cardiol,2007

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimización médica pre-TAVI guiado por el antígeno carbohidrato 125: impacto en la calidad de vida y resultados clínicos;Revista Española de Cardiología;2024-09

2. Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes;Revista Española de Cardiología (English Edition);2024-09

3. Elevated CA125 values predict adverse outcomes in acute heart failure.;Investigación Clínica;2024-08-22

4. Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure;Diagnostics;2024-04-10

5. Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme;European Journal of Heart Failure;2024-03-04